Article info
Systemic sclerosis
Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis
- Correspondence to Professor Florence Sabatier, Cell Therapy Department, Hôpital de la Conception, Assistance Publique Hôpitaux de Marseille, Marseille 13005, France; florence.sabatier{at}ap-hm.fr
Citation
Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis
Publication history
- Received July 31, 2018
- Revised October 31, 2018
- Accepted November 16, 2018
- First published January 5, 2019.
Online issue publication
April 09, 2023
Article Versions
- Previous version (2 August 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.